Clinical Trials Directory

Trials / Completed

CompletedNCT06306417

A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome

Department of Traditional Chinese Medicine (TCM), Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing 100191, China.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

To determine the efficacy and safety of 2 different treatment modalities: 1) acupuncture plus lifestyle management (treatment group), 2) placebo plus lifestyle management (control group) in the treatment of insulin resistance in PCOS patients.

Detailed description

A prospective, randomized controlled trial design was used to select women with polycystic ovary syndrome as the research subjects. 144 subjects who met the inclusion and exclusion criteria were randomly divided into an acupuncture plus lifestyle intervention group (treatment group) and a placebo plus lifestyle intervention group (control group). The differences in glucose metabolism and reproductive endocrinology were compared between the two groups. 1. To verify the efficacy and safety of acupuncture intervention on insulin resistance in PCOS; 2. To explore the effects of acupuncture on androgen and lipid levels, ovarian function, reproductive dysfunction, mood and quality of life in women with PCOS.

Conditions

Interventions

TypeNameDescription
OTHERlifestyle interventionlifestyle intervention
DEVICEacupunctureacupuncture
DEVICESham acupunctureSham acupuncture

Timeline

Start date
2023-09-28
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2024-03-12
Last updated
2025-06-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06306417. Inclusion in this directory is not an endorsement.